MMF Found Superior to Azathioprine for Lupus Nephritis Maintenance

Share this article:

A new large, international study has found that the immunosuppressant drug mycophenolate mofetil (MMF) is superior to azathioprine as a maintenance therapy for patients with lupus nephritis.  John Schieszer reports in today's Medical Minute that lupus nephritis patients appear to respond to MMF for a longer period of time and suffer fewer negative side effects.
Share this article:
You must be a registered member of RUN to post a comment.

Next Article in The Medical Minute

Sign Up for Free e-newsletters

More in The Medical Minute

New Link Between Exercise, PCa Found in Blood Vessels

Researchers found that PCa patients who walked at a faster pace were more likely to have healthier blood vessels.

Melatonin Levels Affect Prostate Cancer Risk

Researchers conducted a study in Iceland that found an association between prostate cancer risk and quality of sleep.

Geographic Differences for Children on Donor Waitlist

A new study is suggesting there is substantial geographic variation in deceased donor kidney waiting times.